Michael Ludwig
Analyst · B. Riley FBR
Thank you, Bruce. Good afternoon, everyone. Before I discuss the results, I would also like to express my thanks and admiration to the employees of Rogers around the globe for an outstanding performance of delivering products to our customers in a challenging, unprecedented business and social environment. While we experienced minor disruptions and increased costs, the Rogers community demonstrated resilience and creativity in the face of uncertainty and anxiety to demonstrate their commitment to their jobs and our customers. Great results, team. In the slides ahead, I’ll review our first quarter results, followed by our second quarter guidance. Turning to slide 11, first quarter revenues, as previously noted, were $198.8 million, 3% higher than Q4 2019 and at the high end of our guidance range of $185 million to $200 million. Strong demand for power semiconductor substrates and battery materials serving EV/HEV applications, increased demand for products serving ADAS applications, as well as an increase in general industrial revenues in Elastomeric Materials were the primary drivers for the increased revenues. Revenues decreased in portable electronics and materials serving aerospace and defense applications. Disruptions of the business environment in China resulting from the coronavirus pandemic negatively impacted our portable electronics and wireless infrastructure demand in the first quarter. We saw orders increase for these applications in the second half of the first quarter as the environment in China improved. Our gross margin for the first quarter was 33%, at the midpoint of our guidance range of 32.5% to 33.5%. In the quarter we experienced a less favorable product mix of higher power semiconductor substrates and lower portable electronic revenues, and we incurred incremental costs associated with the coronavirus pandemic as we temporarily expanded certain benefits to provide employees additional support to care for their families. Improved operations execution resulted in material cost reductions, efficiencies and yield improvements in the first quarter, mitigating the unfavorable product mix and the incremental pandemic-related costs. Adjusted operating income for Q1 2020 was $22.6 million, or 11.3% of revenues, a slight decrease from Q4 of 11.6% of revenues. GAAP net income for the first quarter of $13.3 million represents a $42.1 million improvement compared to the fourth quarter net loss. The loss in the fourth quarter of $28.8 million included a $43.9 million non-cash after-tax charge which resulted from terminating a pension plan in the quarter. On an adjusted basis, the company delivered EPS of $0.92 per fully diluted share, at the upper end of our guidance range of $0.75 to $0.95. Turning to slide 12, our Q1 2020 revenues of $198.8 million increased $5 million compared to the fourth quarter of 2019. The sequential increase was driven by our PES business segment, up 6%, and our EMS business segment, up 4%, while the ACS business segment’s revenues were flat compared to Q4. Currency exchange rates favorably impacted first quarter revenues by $0.5 million compared to the fourth quarter. The flat ACS revenues compared to Q4 resulted primarily from the 3% increase in wireless infrastructure revenues, primarily in 5G power amp applications, and a 10% increase in ADAS revenues, mitigated by a decline of 8% in aerospace and defense application revenues. While the 5G ramp continued to be delayed in the first two months of Q1, due partly to the coronavirus pandemic impacts in China, the second half of the quarter saw increased orders for 5G applications as China makes a push to continue its aggressive rollout of 5G. ADAS revenues were strong in the first quarter as a result of customers building inventory. Late in the first quarter and continuing into the second quarter, we experienced a significant slowdown of ADAS orders, consistent with several automakers’ announced shutdowns due in large part to the impacts of the pandemic. We expect the slowdown to continue through the second quarter, and it will have a meaningful impact on our ADAS and other automotive businesses at least through Q2. Revenues for aerospace and defense programs declined sequentially off a strong fourth quarter base but did increase year-over-year. We continue to be positive on this market and expect continued year-on-year growth. Revenues in our EMS segment increased sequentially, due primarily to orders in general industrial applications, robust growth in a small but growing base for EV battery pad materials and nice growth in our mass transit business. The increase in general industrial demand, which comprised over 45% of the segment’s revenues in the quarter, pointed to our preferred converters refilling inventory levels, as opposed to an increase in end user general industrial demand. In fact, we expect the demand for these materials to soften in the second quarter with the general economic slowdown. Portable electronic revenues, which comprised almost 25% of the revenues of the quarter, declined meaningfully in the quarter, particularly in China, resulting partially from the business disruption caused by the coronavirus pandemic. Late in the quarter, we saw a pickup in demand as China economy came back online, but we do not expect the increased demand to carry through the second quarter, as the impact of the coronavirus pandemic will temper global demand for portable electronics. PES revenues increased in the first quarter due to a strong demand in our EV/HEV applications, both for power semiconductor substrates as well as laminated busbars for power distribution. The semiconductor substrate revenues, which accounted for approximately 25% of the segment revenues, increased 28% compared to the fourth quarter, and the laminated busbar revenues for EV/HEV, which accounted for less than 10% of the segment revenues, grew 18% sequentially. While we enjoyed nice sequential growth in our EV/HEV business in the first quarter, we expect demand for this business to decline in the second quarter, as a significant end customer shut down production in certain locations to address the coronavirus threat. We also had revenue gains in renewable energy applications, which comprise greater than 15% of segment revenues. Power semiconductor substrates for general industrial applications, which comprised over 30% of the segment revenues, were down slightly compared to Q4. These industrial equipment applications generally track with manufacturing CapEx spending. As such, we expect demand to soften in the second quarter as CapEx spending declines, resulting from the economic downturn. Turning to slide 13, our gross margin for Q1 2020 was $65.6 million, or 33% of revenues, slightly less than the 33.1% achieved in Q4. The decrease in the gross margin percentage was due primarily to the negative product mix discussed earlier and the higher incremental costs associated with the coronavirus pandemic as we temporarily expanded certain benefits to provide additional support to our employees. We continued to improve our operational performance through our ongoing focus on lowering material costs and increasing efficiencies in yields in all business segments, mitigating the negative impact of product mix and the incremental costs to address the pandemic. Tariffs were lower in the quarter compared to Q4, resulting from our efforts to leverage our global factory footprint and shift production to facilities that mitigated tariff costs. As a result, we expect the tariffs to have less than a 25 basis point impact on gross margins going forward. Gross margins increased significantly for ACS in the first quarter, as cost reduction efforts and decreased tariffs benefited the margin. The EMS gross margin was essentially flat on a percentage basis in the quarter, as the benefit of volume increases were offset by an unfavorable product mix resulting from lower portable electronic revenues in Q1. In the first quarter, we continued to execute on the PES recovery plan. As Bruce mentioned, we are encouraged by the continued signs of progress made in the quarter for manufacturing yield and continued material cost reductions. We did not see these benefits materialize in the gross margin due to an unfavorable product mix in our Curamik business, direct labor efficiency challenges that were pandemic-related and reserves taken on excess inventory resulting from past material planning challenges. The operational execution work continues, and we are encouraged and confident we will capture the incremental 600 basis points of improvement in this business, subject to increased volumes, which will result in over a 100-basis-point improvement in the company gross margin. While we expect continued improvement in the efficiencies and yields in this business segment in the coming quarters, the pace of the gross margin improvement will be volume-dependent. Slide 14 details changes to adjusted net income for Q1 2020 of $17.2 million, compared to adjusted net income for Q4 of $21.3 million. As discussed earlier, the adjusted operating income for Q1 2020 of $22.6 million and 11.3% of revenues was slightly higher than Q4’s adjusted operating income on a dollar basis but slightly lower as a percent of revenues. Adjusted operating expenses for Q1 of $43.1 million, or 21.7% of revenues, were $1.4 million higher than Q4 adjusted operating expenses. The higher dollar expenses resulted from increased performance based costs compared to Q4. Rogers incurred higher tax expenses in Q1 compared to Q4 while achieving an effective tax rate of 20.6%, in line with our forecasted rate of 20% to 21%. We now expect our effective tax rate for 2020 will be 24% to 25%, higher than our previously communicated effective tax rate of 20% to 21% due to an increase in reserve for uncertain tax position, a lower benefit from discreet tax items anticipated in 2020 and the anticipated geographic mix of pretax income. Overall, the financial impact on the company’s first quarter result from the coronavirus pandemic were not significant. As Bruce mentioned, we did experience a very small increase in our EMS revenues from the sale of materials into medical applications to address the pandemic. We experienced higher cost of goods sold expenses in the form of increased support costs for our employees, approximately $0.6 million, as well as higher freight costs to distribute products. Finally, certain of our operating expenses were lower in Q1 as a result of less travel and less recruiting. All costs and benefits resulting from the pandemic are included in our pro forma results. Turning to slide 15, we ended the first quarter with a cash position of $308.3 million, an increase of $141.4 million from December 31. The increase resulted from a $150 million draw on our revolving credit facility in March, which I’ll discuss later. We ended the first quarter with a net cash position, cash and equivalent balance in excess of amounts owed under our revolving credit facility, of $35.3 million. In Q1, the company spent $11.2 million on capital expenditures. In our last call, we communicated a CapEx spend range of $40 million to $45 million for 2020. We are closely managing our planned capital spending in this difficult economic environment. At this time, we expect to come in at the lower end of the range but are not yet prepared to adjust our range, as we believe there are growth opportunities, particularly EV/HEV programs that may require additional capacity. The company generated $8.6 million from operating activities in Q1, net of an increase in working capital of $18.5 million, primarily from the increase in accounts receivable due to the timing of revenues late in the first quarter. As a result of the cash used for working capital, Q1 free cash flow was negative $2.5 million. In March, the company drew $150 million on its revolving credit facility as a precautionary measure against a potential significant and protracted economic downturn resulting from the financial impacts of the coronavirus pandemic. The company does not presently expect to require this cash to fund its current or future operation and has invested the cash in short term government-backed securities. At March 31, the company had an outstanding balance on its revolving credit facility of $273 million. The company has $177 million available on its revolving credit facility and has an uncommitted accordion option of $175 million. The required payment terms are interest-only, on a monthly basis. The revolving credit facility has interest coverage and leverage covenants, which the company was in compliance with at the end of Q1 and continues to be in compliance with at this date, with significant headroom against the covenant limits. The revolving credit agreement expires in February 2022. The company ended the first quarter with a healthy balance sheet, net cash position, and is well positioned to withstand the current economic challenges and to invest in growth opportunities. Our current cash flow breakeven level is greater than 20% lower than our first quarter revenues on a run-rate basis, depending on the product mix of revenues, and we have the ability to flex our costs with changing demand levels. In this economic environment we will continue to closely manage spending levels and make prudent investments in capital, but we will look to invest in opportunities to accelerate growth out of the downturn. Taking a look at our Q2 2020 guidance, on slide 16, we see opportunities and challenges that were discussed by Bruce and me. The resumption of the 5G rollout in China in late Q1 and continuing into Q2 will provide some buffer against the very challenging automotive demand landscape, where several OEMs and Tier 1s have closed plants indefinitely, impacting our conventional automotive and our EV/HEV business. In addition, we believe our general industrial business in both EMS and PES will be impacted by the significant economic downturn we expect in the second quarter, and possibly longer, resulting from the coronavirus pandemic. We do, however, expect to see incremental revenues for medical applications addressing the needs of the coronavirus pandemic of greater than $0.6 million in the second quarter. While Rogers employees did an outstanding job managing the supply chain and delivering products to customers in Q1, the impact of the pandemic on supply chain and employee availability is difficult to estimate for the second quarter and second half of 2020. Therefore, our revenue guidance is provided with the assumption that our supply chain will continue to supply critical materials and we will continue to produce and deliver products for our customers with minimal disruptions. Revenues for Q2 are estimated to be in the range of $190 million to $205 million. Similar to our guidance for Q1, the range for Q2 is wider than historically provided, due to the increased level of uncertainty from the potential impact of the coronavirus pandemic. We will continue to monitor and flex our spending for manufacturing infrastructure, SG&A and capital expenditures to address the anticipated demand levels. We will also continue our progress on lowering costs, improving efficiencies and improving yields in all businesses, with added focus on PES, as discussed earlier. Even with these actions, the low volumes will continue to negatively impact our gross margin in Q2. In addition, we expect the incremental costs associated with the expanded benefit provided to employees as well as supplies to keep our employees safe resulting from the pandemic to increase in Q2, to approximately $3.5 million to $4 million. As a result, we are guiding gross margin in the range of 32.5% to 33.5% for Q2. We also expect to reduce certain OpEx spending in Q2, principally travel-related and recruiting expenses, by approximately $1 million as a result of the coronavirus pandemic. We guide GAAP Q2 earnings in the range of $0.58 to $0.78 per fully diluted share. On an adjusted basis, we guide fully diluted earnings in the range of $0.80 to $1 per share for the second quarter. Our adjusted results are inclusive of all incremental costs and benefits resulting from the coronavirus pandemic. I will now turn the call back over to the operator for questions.